Geir Åge Løset
Amministratore Delegato presso Nextera AS
Posizioni attive di Geir Åge Løset
Società | Posizione | Inizio | Fine |
---|---|---|---|
Nextera AS
Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Amministratore Delegato | - | - |
Fondatore | 01/01/2009 | - | |
Direttore Tecnico/Scientifico/R&S | 01/01/2009 | - |
Storia della carriera di Geir Åge Løset
Precedenti posizioni note di Geir Åge Løset
Società | Posizione | Inizio | Fine |
---|---|---|---|
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - | - |
University of Oslo | Corporate Officer/Principal | - | - |
Formazione di Geir Åge Løset
University of Oslo | Doctorate Degree |
Statistiche
Distribuzione geografica
Norvegia | 3 |
Danimarca | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Commercial Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Nextera AS
Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Commercial Services |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Geir Åge Løset
- Esperienza